Stay updated on Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    Change Detected
    Summary
    The value of Last Update Posted (Estimated) Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the information provided on the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:49:23.000Z thumbnail image
  5. Check
    4 days ago
    Change Detected
    Summary
    The value for Last Update Posted has changed from 2024-05-31 to 2024-06-12, indicating an update in the information provided on the webpage.
    Difference
    0.5%
    Check dated 2024-06-12T21:45:43.000Z thumbnail image
  6. Check
    11 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a shift in the antitumor activity evaluation of cabozantinib s-malate for Ewing sarcomas and osteosarcoma patients, specifically in terms of 6-month objective response and non-progression criteria.
    Difference
    0.1%
    Check dated 2024-06-06T14:47:03.000Z thumbnail image
  7. Check
    14 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change represents an update in the estimated study completion date for the clinical trial investigating the effectiveness of cabozantinib s-malate in treating patients with relapsed osteosarcoma or Ewing sarcoma.
    Difference
    0.0%
    Check dated 2024-06-03T13:37:14.000Z thumbnail image
  8. Check
    16 days ago
    Change Detected
    Summary
    The value 29 28 29 2024 05 on the webpage has recently changed to 31 30 (Estimated) 31 2023 12. This change likely represents an update in the study completion date for the clinical trial investigating the effectiveness of cabozantinib s-malate in treating patients with relapsed osteosarcoma or Ewing sarcoma.
    Difference
    0.3%
    Check dated 2024-06-01T12:00:23.000Z thumbnail image
  9. Check
    17 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change represents an update in the estimated study completion date for the clinical trial investigating the effectiveness of cabozantinib s-malate in treating patients with relapsed osteosarcoma or Ewing sarcoma.
    Difference
    0.0%
    Check dated 2024-05-31T11:06:09.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.